Immunotherapy – new perspective in lung cancer

doi:10.5306/wjco.v11.i5.250

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9908)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

642

WORD

248

HTML

6107

Figures (1-1)

400

Tables (1-1)

357

Sum=7754

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

865

Download

1289

Sum=2154

May 24, 2020 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. May 24, 2020; 11(5): 250-259
Published online May 24, 2020. doi: 10.5306/wjco.v11.i5.250

Open in New Tab Full Size Figure Download Figure

Figure 1 Safety level for indication of immunotherapeutic drugs in the treatment of lung cancer. SCLC: Small-cell lung cancer; NSCLC: Non-small-cell lung cancer.

Citation: Pinheiro FD, Teixeira AF, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Immunotherapy – new perspective in lung cancer. World J Clin Oncol 2020; 11(5): 250-259
URL: https://www.wjgnet.com/2218-4333/full/v11/i5/250.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i5.250